SGLT2 Inhibitors and GLP-1 Agonists: A Beacon of Hope for Stroke Prevention in Diabetes

Diabetes Metab J. 2024 Mar;48(2):213-214. doi: 10.4093/dmj.2024.0079. Epub 2024 Mar 22.NO ABSTRACTPMID:38556704 | PMC:PMC10995490 | DOI:10.4093/dmj.2024.0079

Source: Diabetes and Metabolism Journal - April 1, 2024 Category: Endocrinology Authors: Jae-Han Jeon Source Type: research